Xiangan Zhang

Xiangan Zhang


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

18 August 2026 in Journal of King Saud University Computer and Information Sciences
Verified
Journal Article
Open access
PDF file
HZHao Zhang
Hao Zhang
XZXiangan Zhang
Xiangan Zhang
MSMenghua Shi
Menghua Shi
MTMengmeng Tang
Mengmeng Tang
Intestinal endoscopic images are frequently degraded by uneven illumination, motion blur, and specular reflections, which tend to cause diffuse lesion boundaries and obscure micro-lesions. Moreover, conventional multi-scale feature fusion methods struggle to accommodate the drastic scale variations of lesions induced by fluctuating shooting distances. To address these challenges, this paper proposes a Cascaded Attention-Driven Dynamic Multi-Scale Feature Fusion Network(CADM-Net). The network first constructs a Multi-Kernel Residual Block to perform parallel multi-scale feature extraction, thereby effectively preserving the fine-grained details of micro-lesions. Subsequently, a Dynamic Multi-Scale Attention mechanism is introduced, which leverages learnable context aggregation and serial dual-attention calibration to adaptively perceive and respond to severe lesion scale variations. Finally, a dedicated Feature Fusion Module is designed to alleviate cross-level semantic misalignment and further refine diffuse lesion boundaries. These modules operate synergistically to significantly enhance the network’s robustness against endoscopic imaging degradation and ensure precise segmentation of lesion regions across varying scales. Extensive experimental results on four public polyp benchmark datasets demonstrate that CADM-Net consistently surpasses existing state-of-the-art methods, achieving superior segmentation accuracy and boundary delineation under diverse imaging conditions.

22 May 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
YAYongkang An
Yongkang An
FWFang Wu
Fang Wu
MSMenghua Shi
Menghua Shi
HLHuan Li
Huan Li
LZLinhan Zhang
Linhan Zhang
XZXiangan Zhang
Xiangan Zhang
Background: Ulcerative colitis (UC) is a chronic relapsing inflammatory bowel disease with limited treatment options. Schisandrin B (Sch B), a bioactive lignan from Schisandra chinensis, has shown anti-inflammatory effects, but its regulatory mechanisms on autophagic flux and non-classical pyroptosis in UC remain unclear.Purpose: To investigate whether Sch B ameliorates colonic inflammation in UC rats by regulating P62-mediated autophagic flux and the P65/caspase4 signaling axis.Study design:In vivo animal study.Methods: A UC model was established in male SD rats using 2,4,6-trinitrobenzenesulfonic acid (TNBS). Rats were randomly divided into six groups(n=10 each): blank control, model, mesalazine (100 mg/kg), and Sch B low(10 mg/kg), medium(20 mg/kg), and high dose(50 mg/kg). Treatments were administered orally for 14 days. Disease activity index (DAI), colonic mucosal injury index(CMDI), and histopathological changes(HE staining) were assessed. Protein expression and localization of P62 and caspase4 were detected by immunohistochemistry (IHC). Western blotting was used to measure P62, phosphorylated P65(P-P65), total P65, and caspase4. Serum levels of IL-18, IL-17A, and IL-10 were measured by ELISA.Results: Compared with the blank group, the model group showed significantly increased DAI and CMDI scores, severe colonic mucosal damage, elevated P62 expression(P<0.01), increased P-P65/P65 ratio, upregulated caspase4 expression, higher serum IL-18 and IL-17A(P<0.01), and lower IL-10(P<0.01). Compared with the model group, Sch B(20 and 50 mg/kg) significantly ameliorated these changes in a dose-dependent manner(P<0.05 or P<0.01), with the high-dose group showing the most pronounced effects.Conclusion: Sch B effectively alleviates TNBS-induced colonic inflammation in UC rats by restoring P62-mediated autophagic flux, inhibiting P65 phosphorylation, downregulating caspase4-mediated non-classical pyroptosis, and rebalancing serum IL-18, IL-17A, and IL-10 levels.

8 June 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
YAYongkang An
Yongkang An
FWFang Wufang
Fang Wufang
LZLinhan Zhang
Linhan Zhang
MSMenghua Shi
Menghua Shi
SZShuangxi Zhang
Shuangxi Zhang
XZXiangan Zhang
Xiangan Zhang
Objective: Choosing between TNBS/ethanol enema and DSS free-drinking water protocols for establishing rat ulcerative colitis(UC) models remains a practical challenge in preclinical research. Beyond confirming that both methods induce colitis, no prior study has quantified the independent contribution of enema procedural trauma to inflammatory readouts, reported sex-stratified cytokine responses, or formally linked model-specific immune profiles to human UC endotypes. Methods: Ten SPF-grade SD rats(half male and half female) were allocated to a normal control, a procedure-matched saline enema control(anesthesia and enema without chemical agent), a TNBS group(100 mg/kg TNBS + 50% ethanol enema), and a DSS group(3% DSS free-drinking, 7 days). Endpoint assessments included body weight, colon length, macroscopic and histological scoring(modified Macpherson criteria, 0–10), and serum TNF-α and IL-6 by ELISA. Post-hoc exploratory analyses included sex-stratified cytokine sub-analysis and coefficient of variation(CV%) for each readout. Results: Both model groups successfully induced UC( P< 0.05 vs. controls for all endpoints). Critically, the procedure-matched saline enema control confirmed that colonic inflammation in the TNBS group was attributable to the chemical agent rather than mechanical trauma. TNBS induced significantly higher TNF-α(90.2±10.5 vs. 73.5±9.8 pg/mL, P< 0.05) and IL-6(66.5±8.3 vs. 53.2±7.6 pg/mL, P< 0.05) than DSS,consistent with Th1-polarized vs. innate barrier-disruption immune endotypes, respectively. Coefficient of variation analysis indicated greater intra-group variability in TNBS versus DSS, reflecting the procedural dependency of enema-based models. Conclusion: A procedure-matched control design is essential for valid TNBS-vs.-DSS comparisons and has been systematically underutilized in prior studies. Based on immune endotype alignment, TNBS is recommended for screening T-cell-targeted therapies and acute anti-inflammatory agents, while DSS is recommended for epithelial barrier repair and microbiome-modulating interventions. A model-selection decision framework derived from these data is provided to guide preclinical study design.